Certara Inc
NASDAQ:CERT

  • LAST PRICE
    15.9300
  • TODAY'S CHANGE (%)
    -0.2800 (-1.7273%)
  • Bid / Lots
    15.7500/ 1
  • Ask / Lots
    17.4300/ 1
  • Open / Previous Close
    16.2400 / 16.2100
  • Day Range
    15.8300
    16.3450
  • 52 Week Range
    11.8100
    24.9600
  • Volume
    610,374

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Software Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
CERT
Certara Inc
2.6B
-45.8x
---
INTA
Intapp Inc
2.2B
-38.1x
---
SPT
Sprout Social Inc
2.9B
-42.8x
---
CLBT
Cellebrite DI Ltd
2.1B
-24.2x
---
AI
C3.ai Inc
2.5B
-8.9x
---
NABL
N-Able Inc
2.3B
96.9x
---
As of 2024-04-20

Company Information

Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development in the global biopharmaceutical industry. It is focused on producing medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its customers include life sciences companies of all sizes along with contract research organizations, academic institutions, and global regulators. Its software and service are used by approximately 2,400 biopharmaceutical companies and academic institutions across 66 countries, including 38 of the top 40 biopharmaceutical companies. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, Netherlands, Philippines, Poland, Portugal, Spain, Switzerland, Egypt, and the United Kingdom.

Contact Information

Headquarters
4 Radnor Corporate Center, Suite 350RADNOR, PA, United States 19087
Phone
609-716-7900
Fax
302-636-5454

Executives

Independent Chairman of the Board
James Cashman
Chief Executive Officer, Director
William Feehery
Chief Financial Officer
John Gallagher
President - Simcyp
Robert Aspbury
President - Software
Leif Pedersen

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$2.6B
Revenue (TTM)
$354.3M
Shares Outstanding
160.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.63
EPS
$-0.35
Book Value
$6.55
P/E Ratio
-45.8x
Price/Sales (TTM)
7.2
Price/Cash Flow (TTM)
3,574.0x
Operating Margin
-11.51%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.